Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder

OBJECTIVE: We examine weight gain and metabolic consequences of risperidone monotherapy in children with autism spectrum disorder (ASD). METHOD: This was a 24-week, multisite, randomized trial of risperidone only versus risperidone plus parent training in 124 children (mean age 6.9 ± 2.35 years; 105...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Acad Child Adolesc Psychiatry
Main Authors: Scahill, Lawrence, Jeon, Sangchoon, Boorin, Susan J., McDougle, Christopher J., Aman, Michael G., Dziura, James, McCracken, James T., Caprio, Sonia, Arnold, L. Eugene, Nicol, Ginger, Deng, Yanhong, Challa, Saankari A., Vitiello, Benedetto
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4851735/
https://ncbi.nlm.nih.gov/pubmed/27126856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaac.2016.02.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados